Caris

Sequences tumor DNA and RNA to uncover the variants driving a patient's cancer and point to targetable treatments.

Vetted listingTakes insuranceFinancial aid available

DiagnosticsTesting3 offerings

Consented intake · your records travel with you · nothing moves without your sign-off

Why Caris exists

Caris performs DNA and RNA sequencing on tumor tissue to map the genetic changes driving a patient's cancer. It looks for variants of interest that can be targeted for treatment and for transcriptome abnormalities that may inform therapy. For patients considering options such as a personalized vaccine, whole exome raw data can serve as a key input.

Results typically in less than two weeks; some tests report in 1 to 9 daysCLIA certifiedCAP accreditedISO 15189 accreditedNew York State approved

1
Physician orders the test
A physician orders a Caris test using a tissue sample, a blood draw, or a pathology slide for certain breast cancers.
2
Sample is analyzed in the lab
The sample is analyzed in Caris laboratories, where medical experts examine the biomarkers driving the specific cancer.
3
Report goes to the physician
Caris delivers a detailed report to the physician showing the DNA, RNA, and protein alterations unique to the cancer.
4
Treatment planning
The physician uses the results to identify therapies with potential benefit, flag treatments unlikely to work, and connect the patient to clinical trials.

Prefer the source? Caris's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

What they offer

Diagnostics

Caris Molecular Intelligence provides comprehensive tumor profiling to match patients with targeted therapies and clinical trials.

Testing· 2

Uncover any abnormalities in the transcriptome that may inform treatment
Uncover what genetic coding is driving my cancer, especially those variants of interest that can be targeted for treatment

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Caris handles billing.

Insurance

Accepted

Financial aid

Available

Prior auth

Required

In-network carriers

MedicareBlue Cross Blue ShieldUnitedHealthcare

Build a personalized cost estimate

Common questions about Caris

Does Caris take insurance?

Caris accepts insurance; In-network carriers include Medicare, Blue Cross Blue Shield, UnitedHealthcare; financial assistance is available. Add your plan on OpenCancer to check coverage before you commit.

How does Caris work?

1. Physician orders the test — A physician orders a Caris test using a tissue sample, a blood draw, or a pathology slide for certain breast cancers. 2. Sample is analyzed in the lab — The sample is analyzed in Caris laboratories, where medical experts examine the biomarkers driving the specific cancer. 3. Report goes to the physician — Caris delivers a detailed report to the physician showing the DNA, RNA, and protein alterations unique to the cancer. 4. Treatment planning — The physician uses the results to identify therapies with potential benefit, flag treatments unlikely to work, and connect the patient to clinical trials.

How long does Caris take?

Results typically in less than two weeks; some tests report in 1 to 9 days

How do I connect with Caris?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Understand this before you decide

Talk to Your Physician

Testing Consent

Financial Services

Patient Resources

Ask about this service

Answers grounded in Caris's details here. Educational only; your oncologist directs treatment.

Who this is for

Cancer types served

bladderbrainbreastcolorectalgastriclungmelanomaovarianpancreaticprostate

Also consider

Other providers in similar categories.

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.